Fetzima 40mg Capsules

Manufacturer ACTAVIS Active Ingredient Levomilnacipran(lee voe mil NA si pran) Pronunciation lee voe mil NA si pran
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.
đŸˇī¸
Drug Class
Antidepressant
đŸ§Ŧ
Pharmacologic Class
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
🤰
Pregnancy Category
Not available
✅
FDA Approved
Jul 2013
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Fetzima is a medication used to treat depression. It works by helping to restore the balance of certain natural substances in the brain, like serotonin and norepinephrine, which can improve mood and energy levels.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow these steps:

Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
Take your medication at the same time every day.
You can take your medication with or without food.
Swallow the medication whole - do not chew, open, or crush it.
Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better.

Storing and Disposing of Your Medication

To ensure your medication remains effective and safe:

Store your medication at room temperature in a dry place, away from the bathroom.
Keep all medications in a safe and secure location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist or healthcare provider.
Check with your pharmacist for guidance on the best way to dispose of your medication. You may also have access to local drug take-back programs.

What to Do If You Miss a Dose

If you miss a dose of your medication:

Take the missed dose as soon as you remember.
If it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
* Do not take two doses at the same time or take extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Take Fetzima exactly as prescribed, usually once daily with or without food.
  • Do not crush, chew, or open the capsule; swallow it whole.
  • Avoid alcohol while taking this medication, as it can worsen side effects.
  • Be aware of potential side effects like increased blood pressure or heart rate, and report them to your doctor.
  • Do not stop taking Fetzima suddenly without talking to your doctor, as this can cause withdrawal symptoms.
  • Regular exercise and a balanced diet can complement treatment for depression.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Initial: 20 mg once daily for 2 days; then 40 mg once daily. Max: 120 mg once daily.
Dose Range: 20 - 120 mg

Condition-Specific Dosing:

initial_titration: 20 mg once daily for 2 days, then increase to 40 mg once daily. Doses may be increased in 40 mg increments at intervals of 2 or more days, up to a maximum of 120 mg once daily, based on tolerability and clinical response.
maintenance: 40 mg to 120 mg once daily
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (Safety and efficacy not established in pediatric patients <18 years of age)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary (CrCl 50-80 mL/min)
Moderate: Max 80 mg once daily (CrCl 30-49 mL/min)
Severe: Max 40 mg once daily (CrCl 15-29 mL/min)
Dialysis: Not recommended (CrCl <15 mL/min, including end-stage renal disease requiring dialysis)

Hepatic Impairment:

Mild: No dosage adjustment necessary
Moderate: No dosage adjustment necessary
Severe: No dosage adjustment necessary

Pharmacology

đŸ”Ŧ

Mechanism of Action

Levomilnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI). It is the more pharmacologically active enantiomer of milnacipran. It selectively inhibits the reuptake of both serotonin (5-HT) and norepinephrine (NE) in the central nervous system, thereby increasing the synaptic concentrations of these neurotransmitters. The exact mechanism of action in major depressive disorder (MDD) is unknown but is presumed to be related to its potentiation of serotonergic and noradrenergic neurotransmission.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 92%
Tmax: Approximately 6-8 hours (extended-release capsule)
FoodEffect: Food does not significantly affect the absorption or pharmacokinetics of levomilnacipran.

Distribution:

Vd: Approximately 460 L
ProteinBinding: Approximately 22% (low)
CnssPenetration: Yes

Elimination:

HalfLife: Approximately 12 hours
Clearance: Approximately 20 L/hour
ExcretionRoute: Primarily renal (approximately 58% as unchanged drug, 18% as metabolites)
Unchanged: Approximately 58%
âąī¸

Pharmacodynamics

OnsetOfAction: Within 1-2 weeks (antidepressant effects)
PeakEffect: Not precisely defined for clinical effect, but steady-state plasma concentrations are reached within 2-3 days.
DurationOfAction: 24 hours (due to extended-release formulation and half-life)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of Fetzima or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Fetzima is not approved for use in pediatric patients.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of bleeding, including:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding from the gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that enlarge
+ Uncontrollable bleeding
Signs of low sodium levels, such as:
+ Headache
+ Difficulty focusing or memory problems
+ Feeling confused or weak
+ Seizures or changes in balance
Signs of high blood pressure, including:
+ Severe headache or dizziness
+ Fainting or changes in vision
Fast or abnormal heartbeat
Seizures
Feeling extremely tired or weak
Difficulty urinating
Sexual problems, such as:
+ Decreased interest in sex
+ Trouble having an orgasm
+ Ejaculation problems
+ Difficulty getting or maintaining an erection
A potentially life-threatening condition called serotonin syndrome, which may be more likely if you take certain other medications. Seek medical help immediately if you experience:
+ Agitation
+ Changes in balance
+ Confusion
+ Hallucinations
+ Fever
+ Fast or abnormal heartbeat
+ Flushing
+ Muscle twitching or stiffness
+ Seizures
+ Shivering or shaking
+ Excessive sweating
+ Severe diarrhea, stomach upset, or vomiting
+ Severe headache

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical attention:

Upset stomach or vomiting
Constipation
* Excessive sweating

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or thoughts of self-harm
  • New or worsening anxiety, panic attacks, agitation, restlessness, irritability, or insomnia
  • Unusual changes in behavior or mood (e.g., acting aggressive, impulsive, or manic)
  • Symptoms of serotonin syndrome (e.g., confusion, hallucinations, rapid heart rate, sweating, muscle stiffness, twitching, fever, nausea, vomiting, diarrhea)
  • Severe headache, blurred vision, eye pain, or swelling around the eye (signs of angle-closure glaucoma)
  • Signs of bleeding (e.g., unusual bruising, nosebleeds, black/tarry stools)
  • Symptoms of hyponatremia (e.g., headache, confusion, weakness, unsteadiness, memory problems)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
If you have kidney disease, as this may affect how your body processes the medication.
If you have narrow angle glaucoma or are at risk of developing this condition.
If you are currently taking or have recently taken certain medications, including:
+ Linezolid or methylene blue, as these can interact with this medication.
+ Certain drugs for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, within the last 14 days. Taking these medications together can increase the risk of very high blood pressure.
* Other health problems or medications you are taking, including prescription and over-the-counter drugs, natural products, and vitamins. This is not an exhaustive list, and it is crucial to discuss all your medications and health issues with your doctor to ensure safe treatment.

To ensure your safety, it is vital to consult with your doctor and pharmacist about all your medications and health problems before taking this medication. Do not start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Before engaging in activities that require your full attention, such as driving, wait until you understand how this medication affects you.

To minimize the risk of side effects, do not abruptly stop taking this medication without first consulting your doctor. If you need to discontinue use, your doctor will provide guidance on how to gradually stop taking it.

As directed by your doctor, regularly schedule blood tests and other laboratory exams to monitor your condition. Additionally, check your blood pressure and heart rate as instructed by your doctor.

While taking this medication, it is recommended that you avoid consuming alcohol. Before using marijuana, cannabis products, or prescription and over-the-counter medications that may cause drowsiness, consult with your doctor.

Be aware that this medication may increase the risk of bleeding, which can be life-threatening in some cases. Discuss this risk with your doctor.

Certain individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness around the eye, contact your doctor immediately.

This medication can cause low sodium levels, which can be life-threatening and lead to seizures, loss of consciousness, breathing difficulties, or death.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

If you are pregnant, planning to become pregnant, or may be pregnant, inform your doctor. You and your doctor will need to discuss the potential benefits and risks to you and your baby. Taking this medication during the third trimester may increase the risk of bleeding after delivery and potentially cause health problems in the newborn.

If you are breastfeeding, consult with your doctor to discuss any potential risks to your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Tachycardia
  • Hypertension
  • Nausea
  • Vomiting
  • Dizziness
  • Somnolence
  • Convulsions
  • Serotonin syndrome

What to Do:

Seek immediate medical attention or call 911. There is no specific antidote. Treatment should be symptomatic and supportive. Ensure adequate airway, oxygenation, and ventilation. Monitor cardiac rhythm and vital signs. Activated charcoal may be considered if ingested within 1-2 hours. Call 1-800-222-1222 for poison control.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) (concurrent use or within 14 days of stopping MAOI, or starting MAOI within 7 days of stopping levomilnacipran)
  • Linezolid (reversible MAOI)
  • Methylene blue (reversible MAOI)
🔴

Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, indinavir, nelfinavir, saquinavir, telithromycin, nefazodone) - may increase levomilnacipran exposure
  • Serotonergic drugs (e.g., SSRIs, other SNRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, St. John's Wort) - increased risk of serotonin syndrome
  • Drugs that affect hemostasis (e.g., NSAIDs, aspirin, warfarin) - increased risk of bleeding
  • Other CNS depressants (e.g., alcohol, benzodiazepines, opioids) - additive CNS depression
🟡

Moderate Interactions

  • Moderate CYP3A4 inhibitors
  • Drugs that increase heart rate or blood pressure (e.g., sympathomimetics, other SNRIs)
đŸŸĸ

Minor Interactions

  • Not specifically listed as minor, but general caution with drugs metabolized by minor CYP pathways.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Blood Pressure and Heart Rate

Rationale: Levomilnacipran can cause dose-dependent increases in blood pressure and heart rate.

Timing: Prior to initiation

Renal Function (CrCl)

Rationale: Dosage adjustment is required for moderate to severe renal impairment.

Timing: Prior to initiation

Depression Severity and Suicidal Ideation

Rationale: To establish baseline and monitor for worsening symptoms or emergence of suicidality.

Timing: Prior to initiation

History of Mania/Hypomania

Rationale: Risk of activating mania/hypomania in bipolar patients.

Timing: Prior to initiation

Narrow-Angle Glaucoma

Rationale: Risk of mydriasis and acute angle-closure glaucoma.

Timing: Prior to initiation

📊

Routine Monitoring

Blood Pressure and Heart Rate

Frequency: Regularly, especially during dose titration and periodically thereafter

Target: Within patient's normal range or acceptable limits

Action Threshold: Sustained clinically significant increases; consider dose reduction or discontinuation.

Depression Severity and Suicidal Ideation

Frequency: Weekly during initial weeks of therapy and dose changes, then periodically

Target: Improvement in symptoms, absence of suicidal thoughts/behaviors

Action Threshold: Worsening depression, emergence of suicidal thoughts/behaviors, agitation, or unusual changes in behavior; immediate clinical assessment required.

Symptoms of Serotonin Syndrome

Frequency: Ongoing, especially when co-administered with other serotonergic drugs

Target: Absence of symptoms (e.g., agitation, hallucinations, tachycardia, fever, hyperreflexia, incoordination, nausea, vomiting, diarrhea)

Action Threshold: Emergence of symptoms; discontinue levomilnacipran and initiate supportive care.

Symptoms of Hyponatremia

Frequency: Periodically, especially in elderly or volume-depleted patients, or those on diuretics

Target: Absence of symptoms (e.g., headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness)

Action Threshold: Emergence of symptoms; consider serum sodium level check.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, anxiety, panic attacks, insomnia, impulsivity, akathisia, hypomania, mania)
  • Serotonin syndrome (e.g., agitation, hallucinations, delirium, coma, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, tremor, rigidity, myoclonus, hyperreflexia, incoordination, gastrointestinal symptoms)
  • Hyponatremia (e.g., headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, falls)
  • Increased blood pressure or heart rate
  • Urinary hesitation or retention
  • Sexual dysfunction
  • Nausea, constipation, vomiting

Special Patient Groups

🤰

Pregnancy

Use during pregnancy should be avoided unless the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies in pregnant women. Neonates exposed to SNRIs late in the third trimester have developed complications requiring prolonged hospitalization, respiratory support, and tube feeding.

Trimester-Specific Risks:

First Trimester: Limited data, but generally, risk of major congenital malformations is not significantly increased with most antidepressants.
Second Trimester: Limited data.
Third Trimester: Risk of persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome (e.g., respiratory distress, cyanosis, apnea, seizures, temperature instability, feeding difficulty, vomiting, hypoglycemia, hypotonia, hypertonia, hyperreflexia, tremor, jitteriness, irritability, constant crying).
🤱

Lactation

Levomilnacipran is excreted in human milk. Due to the potential for serious adverse reactions in a breastfed infant, including central nervous system effects, the decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: L3 (Moderate risk) - Potential for adverse effects in the infant (e.g., somnolence, poor feeding, weight loss, irritability). Monitor infants for sedation, poor feeding, and poor weight gain.
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients (under 18 years of age). Antidepressants increase the risk of suicidal thoughts and behavior in children, adolescents, and young adults.

👴

Geriatric Use

No overall differences in safety or effectiveness were observed between elderly patients and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Elderly patients may be at increased risk for hyponatremia and falls. Dosage adjustments may be needed based on renal function, which often declines with age.

Clinical Information

💎

Clinical Pearls

  • Levomilnacipran has a higher norepinephrine reuptake inhibition potency relative to serotonin compared to other SNRIs like venlafaxine or duloxetine, which may be beneficial for patients with prominent fatigue or low energy.
  • Always titrate the dose slowly to minimize side effects, especially blood pressure and heart rate increases.
  • Counsel patients on the importance of not abruptly discontinuing the medication to avoid withdrawal symptoms.
  • Monitor blood pressure and heart rate regularly, especially in patients with pre-existing cardiovascular conditions.
  • Be vigilant for signs of serotonin syndrome, particularly when co-prescribing with other serotonergic agents.
  • Consider the renal impairment dosing adjustments carefully, as levomilnacipran is primarily renally eliminated.
🔄

Alternative Therapies

  • Other SNRIs (e.g., Venlafaxine, Duloxetine, Desvenlafaxine)
  • SSRIs (e.g., Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram)
  • Atypical antidepressants (e.g., Bupropion, Mirtazapine, Vortioxetine, Vilazodone)
  • Tricyclic Antidepressants (TCAs)
  • MAOIs (less common due to side effect profile and interactions)
💰

Cost & Coverage

Average Cost: $300 - $500 per 30 capsules (40mg)
Insurance Coverage: Tier 2 or 3 (Specialty/Non-preferred Brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information for patients. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.